TY  - JOUR
A1  - Kraus, Daniel
A1  - Jeinsen, Beatrice von
A1  - Tzikas, Stergios
A1  - Palapies, Lars
A1  - Zeller, Tanja
A1  - Bickel, Christoph
A1  - Fette, Georg
A1  - Lackner, Karl Johannes
A1  - Drechsler, Christiane
A1  - Neumann, Johannes T.
A1  - Baldus, Stephan
A1  - Blankenberg, Stefan
A1  - Münzel, Thomas
A1  - Wanner, Christoph
A1  - Zeiher, Andreas M.
A1  - Keller, Till
T1  - Cardiac troponins for the diagnosis of acute myocardial infarction in chronic kidney disease
T2  - Journal of the American Heart Association
N2  - Background: Patients with chronic kidney disease (CKD) are at high risk of myocardial infarction. Cardiac troponins are the biomarkers of choice for the diagnosis of acute myocardial infarction (AMI) without ST‐segment elevation (NSTE). In patients with CKD, troponin levels are often chronically elevated, which reduces their diagnostic utility when NSTE‐AMI is suspected. The aim of this study was to derive a diagnostic algorithm for serial troponin measurements in patients with CKD and suspected NSTE‐AMI.
Methods and Results: Two cohorts, 1494 patients from a prospective cohort study with high‐sensitivity troponin I (hs‐cTnI) measurements and 7059 cases from a clinical registry with high‐sensitivity troponin T (hs‐cTnT ) measurements, were analyzed. The prospective cohort comprised 280 CKD patients (estimated glomerular filtration rate <60 mL/min/1.73 m2). The registry data set contained 1581 CKD patients. In both cohorts, CKD patients were more likely to have adjudicated NSTE‐AMI than non‐CKD patients. The specificities of hs‐cTnI and hs‐cTnT to detect NSTE‐AMI were reduced with CKD (0.82 versus 0.91 for hs‐cTnI and 0.26 versus 0.73 for hs‐cTnT) but could be restored by applying optimized cutoffs to either the first or a second measurement after 3 hours. The best diagnostic performance was achieved with an algorithm that incorporates serial measurements and rules in or out AMI in 69% (hs‐cTnI) and 55% (hs‐cTnT) of CKD patients.
Conclusions: The diagnostic performance of high‐sensitivity cardiac troponins in patients with CKD with suspected NSTE‐AMI is improved by use of an algorithm based on admission troponin and dynamic changes in troponin concentration.
KW  - biomarker
KW  - chronic kidney disease
KW  - cohort study
KW  - decision aids
KW  - non-ST-segment elevation acute coronary syndrome
Y1  - 2018
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/47841
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-478418
SN  - 2047-9980
N1  - Copyright © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell
This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
VL  - 7
IS  - 19, e008032
SP  - 1
EP  - 10
PB  - Association
CY  - New York, NY
ER  -